Actuate Therapeutics, a Phase 2 biotech developing in-licensed inhibitor therapies for difficult to treat cancers, filed on Friday with...
Read moreMemVerge in collaboration with Micron and SuperMicro showcased a remarkable breakthrough in computing at Nvidia’s GTC conference. MemVerge demonstrated...
Read moreVivodyne, a pioneering biotech company that grows and tests on lab-grown human tissues to accelerate therapeutics discovery and development,...
Read moreClearsense, a PaaS company that partners with healthcare organizations to increase data value, governance, and transparency, today announced it...
Read moreFoldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced that its TRIA valves have...
Read moreLinnaeus Therapeutics, Inc., a Kairos portfolio company focused on the development and commercialization of novel small molecule oncology therapeutics, today...
Read moreSienza Energy, a Caltech-incubated battery company backed by Los Angeles-based philanthropist Dr. Patrick Soon-Shiong and Kairos ventures announced its capacity test...
Read more“Amorphology looks forward to its enhanced and optimized partnership with Liquidmetal Technologies, bringing deep materials science and amorphous metals...
Read moreMemVerge®, a leader in AI-first Big Memory Software, has joined forces with Micron to unveil a groundbreaking solution that...
Read moreAptamer Group plc, the developer of novel Optimer binders, announces the second phase of its on-going partnership with Neuro-Bio, an Oxfordshire-based biotechnology...
Read more